Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Judy S. Kelloway"'
Publikováno v:
Drug Safety. 27:293-306
Sodium oxybate, also known as gamma-hydroxybutyric acid (GHB), was discovered in 1960 and has been described both as a therapeutic agent with high medical value and, more recently, a substance of abuse. The naturally occurring form of this drug is fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ebea4dfd8f4b9c088656769400ba145b
https://doi.org/10.2165/00002018-200427050-00002
https://doi.org/10.2165/00002018-200427050-00002
Autor:
Judy S. Kelloway
Publikováno v:
Annals of Pharmacotherapy. 31:1012-1021
Objective To review the pharmacology, pharmacokinetics, clinical efficacy, and adverse effects of zafirlukast. Therapeutic issues regarding the use of a leukotriene-receptor antagonist as prophylactic antiinflammatory therapy for asthma are also disc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8b952a833fa9f8dbb977f2ea344e7d8
https://doi.org/10.1177/106002809703100912
https://doi.org/10.1177/106002809703100912
Publikováno v:
The Journal of Clinical Pharmacology. 32:1038-1044
The disposition of cefpodoxime after single, oral 200-mg doses of cefpodoxime proxetil (cefpodoxime equivalents) was investigated in an open-label study of six patients with end-stage renal disease currently maintained on hemodialysis. Subjects were
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e84c6bbf1c2cf4d14716d1ee767a68ef
https://doi.org/10.1002/j.1552-4604.1992.tb03808.x
https://doi.org/10.1002/j.1552-4604.1992.tb03808.x
Autor:
Judy S. Kelloway, Curtis A Johnson, Atanu Dutta, Robert Faulkner, Bruce E. Shapiro, Charles E. Halstenson, Stephen W Zimmerman, Douglas S Greene, Alfred Tonelli, John Haynes, Olatunde Kuye
Publikováno v:
Clinical Pharmacology and Therapeutics. 51:32-41
Tazobactam is an irreversible inhibitor of many beta-lactamases. In combination with piperacillin, tazobactam exhibits synergy against many beta-lactamase-producing bacteria. The pharmacokinetics of piperacillin and tazobactam were evaluated in eight
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1cf83cf1c7fd83cde580af3cf860e80c
https://doi.org/10.1038/clpt.1992.5
https://doi.org/10.1038/clpt.1992.5
Publikováno v:
Annals of allergy, asthmaimmunology : official publication of the American College of Allergy, Asthma,Immunology. 84(3)
Background Optimal treatment for persistent asthma requires multiple classes of medication, including antiinflammatory agents and bronchodilators. Inhaled corticosteroids are the most effective antiinflammatory agents available and are recommended by
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c6221b144f0f8df7cc5cc2753f4f77b
https://pubmed.ncbi.nlm.nih.gov/10752917
https://pubmed.ncbi.nlm.nih.gov/10752917
Publikováno v:
Mayo Clinic Proceedings. 70:197
Methemoglobinemia and Oxyhemoglobin Concentration REFERENCES 1. Woosley RL, Chen Y, Freiman JP, Gillis RA. Mechanism of the cardiotoxic actions ofterfenadine. JAMA 1993; 269:15321536 Barbey J. Antihistamines: cardiovascular effects. In: Antihistamine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b488d371c4bf643cf86da46fa6b655a5
https://doi.org/10.4065/70.2.197
https://doi.org/10.4065/70.2.197
Publikováno v:
Archives of Internal Medicine. 154:1349
Background: Noncompliance with medications is one of the most serious problems facing health care today. However, methods to measure compliance have many limitations. Methods: To measure specific drug compliance and dosing frequency of two asthma med
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2e273b4135c40bc67d1a69caa023f8e5
https://doi.org/10.1001/archinte.1994.00420120066007
https://doi.org/10.1001/archinte.1994.00420120066007